GHSI Fundamental Analysis - GUARDION HEALTH SCIENCES INC

Fundamental Rating

Overall GHSI gets a fundamental rating of 5 out of 10. We evaluated GHSI against 35 industry peers in the Personal Care Products industry. While GHSI has a great health rating, there are worries on its profitability. GHSI is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GHSI was profitable.

GHSI had a negative operating cash flow in the past year.

In the past 5 years GHSI reported 4 times negative net income.

In the past 5 years GHSI always reported negative operating cash flow.

1.2 Ratios

GHSI has a better Return On Assets (41.65%) than 100.00% of its industry peers.

The Return On Equity of GHSI (46.34%) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	41.65%
ROE	46.34%
ROIC	N/A

ROA(3y)-59.1%

ROA(5y)-69.74%

ROE(3y)-76.49%

ROE(5y)-84.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 99.10%, GHSI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

Looking at the Gross Margin, with a value of 44.84%, GHSI is in line with its industry, outperforming 41.67% of the companies in the same industry.

GHSI's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	99.1%
GM	44.84%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y14.13%

GM growth 5Y-5.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.

GHSI has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, GHSI has more shares outstanding

There is no outstanding debt for GHSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -5.72, we must say that GHSI is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -5.72, GHSI is doing worse than 94.44% of the companies in the same industry.

GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-5.72

ROIC/WACCN/A

WACC8.73%

2.3 Liquidity

GHSI has a Current Ratio of 16.67. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.

GHSI's Current ratio of 16.67 is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.

GHSI has a Quick Ratio of 16.59. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.

GHSI has a better Quick ratio (16.59) than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	16.67
Quick Ratio	16.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 154.16% over the past year.

Looking at the last year, GHSI shows a very negative growth in Revenue. The Revenue has decreased by -43.45% in the last year.

Measured over the past years, GHSI shows a very strong growth in Revenue. The Revenue has been growing by 67.11% on average per year.

EPS 1Y (TTM)154.16%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%963.44%

Revenue 1Y (TTM)-43.45%

Revenue growth 3Y86.44%

Revenue growth 5Y67.11%

Sales Q2Q%-97.39%

3.2 Future

Based on estimates for the next years, GHSI will show a very negative growth in Earnings Per Share. The EPS will decrease by -110.23% on average per year.

Based on estimates for the next years, GHSI will show a quite strong growth in Revenue. The Revenue will grow by 9.78% on average per year.

EPS Next Y-669.3%

EPS Next 2Y-110.23%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year9.56%

Revenue Next 2Y9.78%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GHSI is valuated cheaply with a Price/Earnings ratio of 7.56.

Based on the Price/Earnings ratio, GHSI is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.

GHSI is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.

The Forward Price/Earnings Ratio is negative for GHSI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	7.56
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

GHSI's earnings are expected to decrease with -110.23% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-110.23%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GHSI has a Yearly Dividend Yield of 153.85%, which is a nice return.

In the last 3 months the price of GHSI has falen by -67.14%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.

GHSI's Dividend Yield is rather good when compared to the industry average which is at 5.66. GHSI pays more dividend than 100.00% of the companies in the same industry.

Compared to an average S&P500 Dividend Yield of 2.35, GHSI pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	153.85%

5.2 History

GHSI is new to the dividend game and has less than 3 years of track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DPN/A

EPS Next 2Y-110.23%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GUARDION HEALTH SCIENCES INC

NASDAQ:GHSI (10/11/2024, 8:01:54 PM)

After market: 3.23 -0.02 (-0.62%)

3.25

-0.01 (-0.31%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)08-12 2024-08-12/amc

Earnings (Next)11-14 2024-11-14/amc

Inst Owners7%

Inst Owner ChangeN/A

Ins Owners206.25%

Ins Owner Change0%

Market Cap4.39M

Analysts82.86

Price Target40.8 (1155.38%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	153.85%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-51.78%

Min Revenue beat(2)-97.77%

Max Revenue beat(2)-5.79%

Revenue beat(4)1

Avg Revenue beat(4)-25.02%

Min Revenue beat(4)-97.77%

Max Revenue beat(4)6.34%

Revenue beat(8)2

Avg Revenue beat(8)-14.67%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	7.56
Fwd PE	N/A
P/S	0.68
P/FCF	N/A
P/OCF	N/A
P/B	0.32
P/tB	0.32
EV/EBITDA	N/A

EPS(TTM)0.43

EY13.23%

EPS(NY)-1.04

Fwd EYN/A

FCF(TTM)-2.9

FCFYN/A

OCF(TTM)-2.9

OCFYN/A

SpS4.76

BVpS10.19

TBVpS10.19

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	41.65%
ROE	46.34%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	99.1%
GM	44.84%
FCFM	N/A

ROA(3y)-59.1%

ROA(5y)-69.74%

ROE(3y)-76.49%

ROE(5y)-84.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y14.13%

GM growth 5Y-5.18%

F-Score6

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	16.67
Quick Ratio	16.59
Altman-Z	-5.72

F-Score6

WACC8.73%

ROIC/WACCN/A

Cap/Depr(3y)9.76%

Cap/Depr(5y)24.37%

Cap/Sales(3y)0.36%

Cap/Sales(5y)4.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)154.16%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%963.44%

EPS Next Y-669.3%

EPS Next 2Y-110.23%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-43.45%

Revenue growth 3Y86.44%

Revenue growth 5Y67.11%

Sales Q2Q%-97.39%

Revenue Next Year9.56%

Revenue Next 2Y9.78%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y22.85%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y52.33%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y51.97%

OCF growth 3YN/A

OCF growth 5YN/A

GUARDION HEALTH SCIENCES INC (GHSI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens